MEDA Pharma GmbH & Co. KG
MEDA Pharma GmbH & Co. KG Patent applications | ||
Patent application number | Title | Published |
---|---|---|
20140194400 | Nasal Pharmaceutical Formulation - The present invention relates to a nasel formulation comprising as its active ingredient an intranasal corticosteroid, and also to a method for prophylaxis or treatment of seasonal or perennial allergic and non-allergic rhinitis and rhinoconjunctivitis. | 07-10-2014 |
20120076739 | Novel combination of anticholinergics-b2-adrenoceptor agonists, antileukotrienes (leukotriene receptor antagonists), glucocorticoids and/or phosphodiesterase 4 inhibitors for the treatment of inflammatory diseases - The invention relates to novel combinations based on anticholinergics, β | 03-29-2012 |
20080300226 | Combination of Anticholinergics and Glucocorticoids for the Long-Term Treatment of Asthma and COPD - The present invention describes the combination of topically inhaled medicinal formulations comprising an anticholinergic component and a glucocorticosteroid component and its use in the symptomatic and prophylactic treatment of diseases of the respiratory tract, especially with an obstructive component or underlying inflammation like asthma and chronic obstructive pulmonary disease (COPD). It further comprises the presentation of this combination in a locally applied (inhaled) formulation and application in an inhalation device for instance in the Novolizer®. | 12-04-2008 |